SoundHealth Receives $7 Million Seed Round Funding and Launches SONU, the World’s First FDA-Authorized, AI-Enabled, Wearable Device for Treating Nasal Congestion Due to Allergic and Non-Allergic Rhinitis
August 12, 2024
SONU is the First Over-the-Counter Device Authorized for At-Home Use that Extends the Toolbox of Treatment Options for Patients and Physicians and Offers a Safe Alternative to Pharmaceutical Treatments
SoundHealth, Inc., a medical technology company harnessing the power of artificial intelligence and medical science to improve patient outcomes, today introduced SONU. SONU is the world’s first FDA De Novo-authorized, AI-enabled, wearable medical device for the treatment of moderate to severe nasal congestion due to allergic and non-allergic rhinitis for at-home use by individuals 22 years of age and older. SONU provides a new non-pharmaceutical treatment option for patients and clinicians. The United States Food and Drug Administration (FDA) issued a De Novo classification for the SONU product, which includes the SONU device and the SONU app.
Download our app to get started
